Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04564443 · ClinicalTrials.gov registry record · NA
A Unique Micro Water Jet Technology Device Versus Standard Debridement in the Treatment of Diabetic Foot
A NA study of Diabetic Foot Ulcer and Diabetic Foot, sponsored by Medaxis.
- Active
- Registry status
- NA
- Development phase
- 222
- Enrollment target
- 6
- Study locations
NCT04564443 is a NA study of Diabetic Foot Ulcer and Diabetic Foot that is active but no longer recruiting, run by Medaxis. The registered enrollment target is 222 participants, below the 252-participant average among 67 other Diabetic Foot Ulcer trials with a reported enrollment target (12% lower). The trial reports 6 study locations across 6 states.
The verdict
NCT04564443, a NA study of Diabetic Foot Ulcer and Diabetic Foot, is active but no longer recruiting, sponsored by Medaxis.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 222 participants
- Enrollment target
- 6
- Study locations
Study Summary
The purpose of this clinical investigation is to assess performance of the Medaxis Debritom+™ and to collect subject outcome data in the treatment of diabetic foot ulcers (DFU) vs Standard sharp debridement.
Conditions Studied
Interventions
- OTHER Medaxis Debritom+
- OTHER Sharp Surgical Debridement
- OTHER Additional Outer Dressing Application
- OTHER Offloading
- OTHER Fibracol Wound Dressing
Study Locations (6)
California
- CCR Research - San Francisco
Florida
- Doctors Research Network - South Miami
Maryland
- Foot and Ankle Associates of the Mid-Atlantic - Frederick
North Carolina
- Foot and Ankle Associates of the Mid-Atlantic - Raleigh
Ohio
- Lower Extremity Institute for Research and Therapy, LLC - Youngstown
Virginia
- Foot and Ankle Associates of the Mid-Atlantic - Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 222 participants |
| Start Date | 2020-09-11 |
| Est. Completion | 2024-12-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04564443
The ClinicalTrials.gov registry entry for NCT04564443 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 222 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 252-participant average among 67 other Diabetic Foot Ulcer trials with a reported enrollment target (12% lower). The listed sponsor is Medaxis, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Diabetic Foot Ulcer appearing as the primary indexed condition, and to 5 interventions - of which Medaxis Debritom+ is the first listed.
NCT04564443 reports 6 study locations spanning 6 distinct geographic areas - top geographies include California, Florida, Maryland.
Frequently Asked Questions
What is clinical trial NCT04564443 about?
NCT04564443 is a clinical study titled "A Unique Micro Water Jet Technology Device Versus Standard Debridement in the Treatment of Diabetic Foot". The purpose of this clinical investigation is to assess performance of the Medaxis Debritom+™ and to collect subject outcome data in the treatment of diabetic foot ulcers (DFU) vs Standard sharp debridement.
What is the current status of trial NCT04564443?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 222 participants. The study started on 2020-09-11. Estimated completion is 2024-12-30.
What conditions does trial NCT04564443 study?
This clinical trial studies the following conditions: Diabetic Foot Ulcer, Diabetic Foot.
What interventions are being tested in trial NCT04564443?
The interventions under investigation include: Medaxis Debritom+ (OTHER), Sharp Surgical Debridement (OTHER), Additional Outer Dressing Application (OTHER), Offloading (OTHER), Fibracol Wound Dressing (OTHER).
Who is sponsoring clinical trial NCT04564443?
This trial is sponsored by Medaxis, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04564443 being conducted?
This trial has 6 study locations across California, Florida, Maryland, North Carolina, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetic Foot Ulcer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Feasibility and Effectiveness of a Remote Monitoring Program for the Treatment of Diabetic Foot Ulcers
RECRUITING · NA
-
Study Assessing Complete Wound Healing by Comparing Surgenex® PelloGraft in Treating DFU and SanoGraft® in Treating VLU to SOC
RECRUITING · NA
-
A Clinical Investigation to Follow the Progress of Exuding Chronic Wounds Using Mepilex® Up as the Primary Dressing.
RECRUITING · NA
-
Modified Platform Trial Evaluating PpLHACM and SOC Versus SOC Alone in the Treatment of Nonhealing DFUs
RECRUITING · NA
-
Derm-Maxx in Patients With Diabetic Foot Ulcers Unresponsive to Standard of Care Treatment Alone
RECRUITING · NA
-
Exercise Enhances Wound Healing in Patients With Diabetic Foot Ulcers
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.